Which version of the Instructions for Use did your doctors's office give you?
If you don’t recognize the images above or if you prefer a physical copy, contact your doctor.
Which version of the Instructions for Use came with your patient's on-body injector?
Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the... Read More
Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non‑myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low white blood cell count.
For more than 15 years, Neulasta® has been used to help reduce the risk of infection resulting from strong chemotherapy. Today, most patients use Neulasta® Onpro® to receive their Neulasta® dose at home instead of having to go back to the doctor’s office.*
A study of 928 patients with breast cancer showed that when given once every chemotherapy cycle, Neulasta® helped protect against the risk of infection and reduced hospitalizations. 17% of patients got infections when not treated with Neulasta®— while only 1% of patients got infections when treated with Neulasta®, a 94% reduction. 14% of patients were hospitalized when not treated with Neulasta®— while only 1% of patients treated with Neulasta® were hospitalized, a 93% reduction.
A study of patients with different types of cancer showed that more patients who received Neulasta® stayed on their chemotherapy regimen than patients who did not receive a white blood cell booster.
The most common side effect of Neulasta® is aching bones or muscles in your arms and legs. If you experience this or any other side effect, talk to your doctor.Learn more about how Neulasta® Onpro®
* If, for any reason, you believe you did not receive your full dose of Neulasta® or that your on-body injector is not working correctly, immediately contact your healthcare provider, as an incomplete dose could increase infection risk.
*For commercially insured
patients, up to annual limit.
Do not take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effect of Neulasta® is pain in your bones and in your arms and legs.
These are not all the possible side effects of Neulasta®. Call your healthcare provider for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.
Please see Neulasta® Patient Information.
Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.
Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe co-packaged with the on-body injector (OBI) for Neulasta® (Neulasta® Onpro® kit).
Important Safety Information
Do not take take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.
Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
• Have a sickle cell disorder